Persistent Trichomoniasis Infection Found in Pregnant Women
|
By LabMedica International staff writers Posted on 29 Aug 2018 |

Image: Trichomonas vaginalis protozoan flagellates that cause a common sexually transmitted disease (Photo courtesy of David M. Raymondo).
Trichomoniasis is a very common sexually transmitted disease (STD). It is caused by infection with a protozoan parasite called Trichomonas vaginalis. Although symptoms of the disease vary, most people who have the parasite cannot tell they are infected.
Trichomoniasis is the most common curable STD. In the USA, an estimated 3.7 million people have the infection. However, only about 30% develop any symptoms of trichomoniasis. Infection is more common in women than in men. Older women are more likely than younger women to have been infected with trichomoniasis.
Scientists at the Medical University of South Carolina (Charleston, SC, USA) determined the rate of persistent T. vaginalis infection among pregnant women post-treatment. Their secondary objective was to determine if oral multi-dose metronidazole was associated with fewer cases of persistent T. vaginalis compared to single dose treatment. The team carried out a retrospective cohort study of women diagnosed with genital T. vaginalis from 2008 to 2017. They calculated the rate of persistent trichomoniasis by dividing the number of positive Trichomonas tests collected ≥ 21 days post-treatment by the total number of women treated and retested.
The physicians reported that 542 women with 565 pregnancies were diagnosed with T. vaginalis infection. The majority of subjects were prescribed either single dose (n=352) or multi-dose metronidazole (n=74). Post-treatment Trichomonas tests were collected ≥ 21 days in 326 subjects and 44% (143) were positive. Rates of positive Trichomonas tests among women receiving single dose and multi-dose regimens were similar (45% versus 40%). Women who had ≥ 1 pregnancy affected by Trichomonas infection were more likely to have a positive test post-treatment. Obese women were less likely to have a positive test post-treatment.
The authors concluded that given high rates of positive Trichomonas tests and increased detection with nucleic acid amplification tests (NAATs); all pregnant women should be retested with NAATs around three weeks post-treatment. Further studies are needed to determine the most effective treatment of Trichomonas infection in pregnant women. The study was published on July 31, 2018, in the journal Sexually Transmitted Diseases.
Related Links:
Medical University of South Carolina
Trichomoniasis is the most common curable STD. In the USA, an estimated 3.7 million people have the infection. However, only about 30% develop any symptoms of trichomoniasis. Infection is more common in women than in men. Older women are more likely than younger women to have been infected with trichomoniasis.
Scientists at the Medical University of South Carolina (Charleston, SC, USA) determined the rate of persistent T. vaginalis infection among pregnant women post-treatment. Their secondary objective was to determine if oral multi-dose metronidazole was associated with fewer cases of persistent T. vaginalis compared to single dose treatment. The team carried out a retrospective cohort study of women diagnosed with genital T. vaginalis from 2008 to 2017. They calculated the rate of persistent trichomoniasis by dividing the number of positive Trichomonas tests collected ≥ 21 days post-treatment by the total number of women treated and retested.
The physicians reported that 542 women with 565 pregnancies were diagnosed with T. vaginalis infection. The majority of subjects were prescribed either single dose (n=352) or multi-dose metronidazole (n=74). Post-treatment Trichomonas tests were collected ≥ 21 days in 326 subjects and 44% (143) were positive. Rates of positive Trichomonas tests among women receiving single dose and multi-dose regimens were similar (45% versus 40%). Women who had ≥ 1 pregnancy affected by Trichomonas infection were more likely to have a positive test post-treatment. Obese women were less likely to have a positive test post-treatment.
The authors concluded that given high rates of positive Trichomonas tests and increased detection with nucleic acid amplification tests (NAATs); all pregnant women should be retested with NAATs around three weeks post-treatment. Further studies are needed to determine the most effective treatment of Trichomonas infection in pregnant women. The study was published on July 31, 2018, in the journal Sexually Transmitted Diseases.
Related Links:
Medical University of South Carolina
Latest Microbiology News
- New WHO Tools Address Gaps in Antimicrobial Resistance Testing
- Complete Malaria Genomes Could Improve Species Identification and Surveillance
- Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum
- Automated Microbial Identification and Susceptibility System Gains FDA Clearance
- Gastrointestinal Flex Assay Gains EU Certification for Tailored Pathogen Testing
- Molecular Panels Gain FDA Clearance for One-Hour Gastrointestinal Pathogen Testing
- Common Genetic Variant Increases Risk of Bacterial Pneumonia
- Rapid Host-Response Assay Gains FDA Clearance to Help Distinguish Bacterial and Viral Infections
- Stool Testing Predicts UTI Risk and Guides Antibiotic Selection
- Repeat Prenatal STI Screening and Treatment May Reduce Preterm Births
- Decentralized Laboratory Network Improves Detection of Viral Hemorrhagic Fevers in Guinea
- Molecular Panel Gains WHO Emergency Use Listing to Support Ebola Outbreak Response
- Rapid Host-Response Test Aims to Predict Corticosteroid Benefit in Sepsis
- Oral and Lung Microbiome Changes Linked to Severe Long Covid Symptoms
- Study Finds Distinct Malaria Parasites Linked to Sickle Cell Trait Protection
- Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis
Channels
Clinical Chemistry
view channel
Study Supports Review of Long-Term Blood-Monitoring Guidelines for Clozapine
Treatment-resistant schizophrenia (TRS) is a severe form of schizophrenia for which clozapine remains the only antipsychotic specifically approved by the U.S. Food and Drug Administration (FDA).... Read more
Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research
Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more
Blood Biomarker Model May Help Estimate Five- and 10-Year Cognitive Impairment Risk
Estimating future cognitive impairment risk remains challenging in cognitively healthy adults, particularly when biomarker findings are reduced to simple positive or negative results. Because mild cognitive... Read moreMolecular Diagnostics
view channel
Multimodal AI Blood Test Aims to Improve Early Lung Cancer Screening
Lung cancer screening can detect stage 1 disease, but false-positive findings, repeated follow-up, and radiation exposure remain important concerns. Current NHS screening is limited to current and former... Read more
FDA Clears Three-Virus Respiratory Panel for Anterior Nasal Swabs
Influenza and respiratory syncytial virus (RSV) often circulate during the same season and cause overlapping symptoms, making accurate differentiation important for clinical management. Seasonal testing... Read moreHematology
view channel
Werfen Gains FDA Clearance for ROTEM sigma Cartridge Use in Trauma
Traumatic injuries account for approximately 10% of deaths worldwide, with uncontrolled bleeding remaining a leading cause of potentially preventable trauma-related death. Trauma-induced coagulopathy further... Read more
Serial Blood Samples Reveal Leukemia’s Evolution Decades Before Diagnosis
Acute myeloid leukemia (AML) is an aggressive blood cancer affecting approximately 2,700 people in the U.K. annually, with only about one in six patients surviving five years after diagnosis.... Read moreImmunology
view channel
Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice
Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more
Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis
Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more
Antibody Testing Informs Melioidosis Diagnosis and Surveillance in Emerging Regions
Melioidosis is a serious and sometimes fatal infection caused by the soil- and water-dwelling bacterium Burkholderia pseudomallei. People and animals can contract the disease through exposure to contaminated... Read morePathology
view channel
AI Prostate Cancer Test Added to NCCN Guidelines for Post-Surgery Recurrence
Following radical prostatectomy, an estimated 20% to 40% of prostate cancer patients develop biochemical recurrence, marked by rising prostate-specific antigen levels that may indicate cancer recurrence.... Read more
New Training Approach Helps AI Distinguish Neighboring Cells in Tissue
Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more
Review Highlights Progress and Validation Needs for AI in Digital Pathology
Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read moreTechnology
view channel
New qPCR Master Mixes Offer Broad Compatibility for Routine Research
Quantitative PCR (qPCR) workflows require consistent reagent performance across instruments and assay formats. Laboratories must also manage costs without changing established protocols.... Read more
Multi-Agent AI Framework Supports Laboratory Quality and Workflow Monitoring
Clinical laboratories analyze blood, urine, tissue, and other bodily fluids to support disease diagnosis and treatment. Rising test volumes, workforce shortages, and increasingly complex diagnostics are... Read moreIndustry
view channel
Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil
Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more







